Navigation Links
Global Mercury Treaty May Include Ban on Mercury in Medicine
Date:8/1/2011

SILVER SPRING, Md., Aug. 1, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, July 22, 2011, the United Nations Environment Programme (UNEP) distributed a revised text for its comprehensive global treaty on mercury.  Advocates for mercury-free drugs were gratified to see pharmaceuticals listed in "Annex C (Mercury-added product not allowed)" of the proposed treaty.

The Coalition for Mercury-free Drugs (CoMeD) helped initiate this addition through its advocacy efforts at the United Nations (UN) negotiations held in Chiba, Japan, in January 2011.  CoMeD President Rev. Lisa Sykes, the mother of a son diagnosed with vaccine-related mercury poisoning, described to representatives of over 150 participating nations how:  "... unnecessarily injecting mercury into pregnant women and children, as part of a vaccine or other drug, is an ongoing and often unrecognized crisis."

Thimerosal (49.6% mercury by weight), still used as a vaccine preservative and in-process sterilizing agent, is an unnecessary, and sometimes undisclosed, component in many vaccines.  Its use is associated with neurodevelopmental disorders, cancer, birth defects and miscarriage.  Those harmed most by Thimerosal in vaccines are the unborn and newborn.

Addressing the diplomats attending the UN meeting in Chiba, Dr. Mark R. Geier of CoMeD observed: "For this treaty to be fully effective, it must make clear that the intentional exposure of humans, especially pregnant women and young children, to mercury, will not be tolerated."  

Dr. Geier's comments were especially well-received by the diplomats from developing nations.  CoMeD representatives met with regional working groups in closed-door sessions and explained the feasibility of using 2-phenoxyethanol, a much less toxic alternative to Thimerosal, in vaccines and other drugs.

Dr. Geier challenged the inequity of providing wealthy nations with vaccines having reduced levels of mercury while poor nations still receive vaccines containing dangerously high levels of mercury: "Children around the world, no matter their place of birth or their income level, deserve safe mercury-free vaccines.  The practice of providing mercury-reduced and mercury-free vaccines to developed countries while insisting that developing nations take mercury-containing ones is wrong."

By the end of negotiations in Chiba, diplomats from developing countries requested the Secretariat to assess the safety of mercury in drugs.  

A team of scientists and advocates from CoMeD will attend the next treaty negotiation in Nairobi, Kenya, from October 31 through November 4, 2011, to support keeping this global ban on mercury-containing drugs in the finalized UN treaty.


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Insulin- Global
2. Global Diagnostic Imaging (CT, MRI, X-Ray & Ultrasound) Market - Competitive Landscape & Forecasts From 2010 to 2016
3. MarketsandMarkets: Global Diagnostic Imaging Market Estimated to Reach $26.6 Billion by 2016
4. Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
5. Orthopaedics: Market Prospects & Global Competition
6. 4th Alzheimers Awards Announced in Search of Global Solutions for Better Dementia Care
7. Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited
8. Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference
9. Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil™
10. Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011
11. Flow Cytometry: Products, Technologies and Global Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
Breaking Medicine News(10 mins):